Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cirtran (CIRX) EBT (2017 - 2025)

Cirtran filings provide 14 years of EBT readings, the most recent being $461442.0 for Q4 2025.

  • On a quarterly basis, EBT rose 152.02% to $461442.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$692311.0, a 74.37% increase, with the full-year FY2025 number at -$701634.0, up 74.03% from a year prior.
  • EBT hit $461442.0 in Q4 2025 for Cirtran, up from -$444890.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $21.2 million in Q4 2023 to a low of -$899953.0 in Q3 2024.
  • Median EBT over the past 5 years was -$300671.0 (2021), compared with a mean of $734261.2.
  • Biggest five-year swings in EBT: surged 5099.08% in 2023 and later crashed 337.39% in 2024.
  • Cirtran's EBT stood at -$304839.0 in 2021, then tumbled by 39.17% to -$424256.0 in 2022, then surged by 5099.08% to $21.2 million in 2023, then tumbled by 104.18% to -$887090.0 in 2024, then skyrocketed by 152.02% to $461442.0 in 2025.
  • The last three reported values for EBT were $461442.0 (Q4 2025), -$444890.0 (Q3 2025), and -$562750.0 (Q2 2025) per Business Quant data.